Patrick Blake Buys 3,097 Shares of Mayne Pharma Group Limited (ASX:MYX) Stock
Patrick Blake Buys 3,097 Shares of Mayne Pharma Group Limited (ASX:MYX) Stock
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the firm's stock in a transaction on Thursday, April 13th. The stock was acquired at an average cost of A$4.07 ($2.73) per share, with a total value of A$12,592.40 ($8,451.28).
Mayne Pharma Group Limited（ASX: MYX — 獲取評級）內部人士帕特里克·布萊克在4月13日星期四的一筆交易中購買了該公司3,097股股票。該股票的收購平均成本爲每股4.07澳元（2.73美元），總價值爲12,592.40澳元（8,451.28美元）。
Mayne Pharma Group Price Performance
梅恩製藥集團的價格表現
The company has a quick ratio of 0.62, a current ratio of 1.45 and a debt-to-equity ratio of 10.18.
該公司的速動比率爲0.62，流動比率爲1.45，債務與權益比率爲10.18。
About Mayne Pharma Group
關於梅恩製藥集團
(Get Rating)
（獲取評分）
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
Mayne Pharma Group Limited是一家專業製藥公司，在澳大利亞、新西蘭、美國、加拿大、歐洲和亞洲生產和銷售品牌和仿製藥產品。該公司通過四個部門運營：Metrics合同服務、國際、品牌產品和組合產品。
Read More
閱讀更多
- Finding New Technology to Invest in: A Guide
- Genuine Parts Company Is Genuinely A Good Buy
- Healthcare Sector: Overview and Keys to Investing
- Can D.R. Horton Shares Raise The Roof, Or Is This The Ceiling?
- American Express Growth Riding On Joyful Consumer Spending
- 尋找可供投資的新技術：指南
- 正品零件公司確實是個不錯的選擇
- 醫療保健行業：概述和投資關鍵
- D.R. Horton 的股票能否抬高屋頂，還是這是上限？
- 美國運通的增長取決於愉快的消費者支出
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
接收梅恩製藥集團每日的新聞和收視率 -在下面輸入您的電子郵件地址，以通過Marketbeat.com的免費每日電子郵件時事通訊接收Mayne Pharma Group及相關公司最新新聞和分析師評級的簡明每日摘要。